Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Zyclara Generic Name & Formulations
Legal Class
Rx
General Description
Imiquimod 3.75%; topical cream; contains parabens.
Pharmacological Class
Immune response modifier.
How Supplied
Single-use packets—28
Manufacturer
Zyclara Indications
Indications
Actinic keratoses on face and balding scalp in immunocompetent patients.
Zyclara Dosage and Administration
Adult
≥18yrs: Apply thin film to affected area (face or balding scalp) and rub in once daily at bedtime; leave on for 8 hours, wash off with mild soap and water. Treat for two 2-week cycles separated by a 2-week no-treatment cycle. Max two packets per application and one treatment course per area. Apply to intact skin only; Interrupt if severe reaction occurs; do not extend treatment cycle due to missed doses or rest periods. Wash hands before/after application.
Children
<18yrs: not recommended.
Zyclara Contraindications
Not Applicable
Zyclara Boxed Warnings
Not Applicable
Zyclara Warnings/Precautions
Warnings/Precautions
Immunosuppressed. Autoimmune conditions. Not for treating urethral, intra-vaginal, cervical, rectal or intra-anal human papilloma viral disease, xeroderma pigmentosum, superficial basal cell carcinoma. Sun sensitivity. Avoid eyes, lips, nose, mouth, mucous membranes, sun or UV light (use sunscreen daily). Do not occlude. Pregnancy (Cat.C). Nursing mothers.
Zyclara Pharmacokinetics
See Literature
Zyclara Interactions
Interactions
Avoid concomitant other forms of imiquimod.
Zyclara Adverse Reactions
Adverse Reactions
Local inflammation (eg, erythema, crusting, erosion, weeping, edema), pruritus, flaking, scaling, dryness, flu-like symptoms (eg, headache, fatigue, nausea, fever, chills, myalgia), transient increase in lesion counts; exacerbation of skin inflammatory conditions (eg, graft vs. host disease), chest pain, lymphadenopathy, hypo- or hyperpigmentation.
Zyclara Clinical Trials
See Literature
Zyclara Note
Not Applicable
Zyclara Patient Counseling
See Literature
Zyclara Generic Name & Formulations
Legal Class
Rx
General Description
Imiquimod 3.75%; topical cream; contains parabens.
Pharmacological Class
Immune response modifier.
How Supplied
Single-use packets—28
Manufacturer
Zyclara Indications
Indications
External genital warts. Perianal warts.
Zyclara Dosage and Administration
Adult
Apply thin layer to warts and rub in once daily prior to bedtime; leave on for 8 hours. Wash off with mild soap and water. Continue until total clearance or for up to 8 weeks. Max one packet per application to treatment area. Interrupt if local skin reaction occurs; resume after several days or once the reaction subsides. Wash hands before/after application.
Children
Not recommended.
Zyclara Contraindications
Not Applicable
Zyclara Boxed Warnings
Not Applicable
Zyclara Warnings/Precautions
Warnings/Precautions
Immunosuppressed. Autoimmune conditions. Not for treating urethral, intra-vaginal, cervical, rectal or intra-anal human papilloma viral disease, xeroderma pigmentosum, superficial basal cell carcinoma. Sun sensitivity. Avoid eyes, lips, nose, mouth, mucous membranes, sun or UV light (use sunscreen daily). Do not occlude. Pregnancy (Cat.C). Nursing mothers.
Zyclara Pharmacokinetics
See Literature
Zyclara Interactions
Interactions
Avoid concomitant other forms of imiquimod.
Zyclara Adverse Reactions
Adverse Reactions
Local inflammation (eg, erythema, crusting, erosion, weeping, edema), pruritus, flaking, scaling, dryness, flu-like symptoms (eg, headache, fatigue, nausea, fever, chills, myalgia), transient increase in lesion counts; exacerbation of skin inflammatory conditions (eg, graft vs. host disease), chest pain, lymphadenopathy, hypo- or hyperpigmentation.
Zyclara Clinical Trials
See Literature
Zyclara Note
Not Applicable
Zyclara Patient Counseling
See Literature
Images
